北美药物基因组学市场预测至 2028 年 - COVID-19 影响和区域分析技术（PCR、测序、微阵列、凝胶电泳、质谱等）、应用（药物发现、肿瘤学、神经病学和精神病学、疼痛管理、心血管疾病）等）和最终用户（医院和诊所、生物制药公司、CRO 和 CDMO 等）
No. of Pages: 160 | Report Code: TIPRE00028873 | Category: Life Sciences
No. of Pages: 160 | Report Code: TIPRE00028873 | Category: Life Sciences
推动该市场增长的关键因素是慢性病患病率不断上升、精准医疗需求激增以及药物基因组学研究活动的资金增加。然而，熟练专业人员的短缺预计将限制预测期内的市场增长。
许多老年人（>60%）患有两种或多种慢性病。双胞胎研究已证实，基因会导致慢性疾病，如心血管疾病 (CVD)、糖尿病、肥胖、类风湿性关节炎、阿尔茨海默病 (AD) 和抑郁症。利用全基因组关联研究 (GWAS) 的分子遗传数据，现在可以测量这些慢性疾病的个体风险。据美国疾病控制与预防中心（CDC）统计，2020年，美国近十分之六的人患有至少一种慢性病，十分之四的人患有两种或两种以上慢性病。
由于忙碌的生活方式，导致动脉粥样硬化、心绞痛、急性心肌梗塞等心血管疾病的死亡率很高。根据世界卫生组织 (WHO) 提供的数据，CVD 是导致死亡的主要原因，每年夺去约 1790 万人的生命。糖尿病是危及生命的疾病之一，无法进行功能性治愈。所有类型的糖尿病都会导致身体不同部位出现各种并发症，并增加过早死亡的风险。心脏病、中风、肾衰竭、截肢、视力丧失和神经损伤是与糖尿病相关的主要并发症。糖尿病病例的显着增加导致了改变人们生活的并发症。据国际糖尿病联合会（IDF）统计，2017年北美报告有4600万糖尿病患者，预计到2045年将达到6200万。
该数据还报告称，2017 年约有 4.25 亿人患有糖尿病，预计到 2045 年将达到 6.29 亿。在预测期内，该疾病的患病率将增加约 35%。据阿尔茨海默病协会称，2020年，全球有5500万人患有阿尔茨海默病。随着慢性病的迅速增加，用于治疗危及生命的疾病的基因组学研究在过去五年中取得了迅速进展，推动了市场的增长。
此外，药物基因组学也在迅速发展在至少 14 个国家总计超过 40 亿美元的政府投资的支持下，在医疗保健系统中过渡到临床实践和实施。这些国家基因组医学计划在现实生活条件下推动变革，同时解决实施障碍并收集证据以供更广泛采用。
2018 年 8 月，波士顿科学公司 (Boston Scientific)总部位于马萨诸塞州的公司 Corporation 宣布获得 430 万美元种子资金，并与 Veritas Genetics 合作。该公司计划利用这笔资金，通过创建一个值得信赖、安全和去中心化的基因组数据市场来支持其进入个人基因组测序时代的使命。 因此，制造商和政府的持续资助基因组学领域正在推动药物基因组学市场。
Strategic insights for North America Pharmacogenomics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 3,333.43 Million |
| Market Size by 2028 | US$ 6,534.83 Million |
| Global CAGR (2021 - 2028) | 10.1% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 技术
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Pharmacogenomics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Pharmacogenomics Market is valued at US$ 3,333.43 Million in 2021, it is projected to reach US$ 6,534.83 Million by 2028.
As per our report North America Pharmacogenomics Market, the market size is valued at US$ 3,333.43 Million in 2021, projecting it to reach US$ 6,534.83 Million by 2028. This translates to a CAGR of approximately 10.1% during the forecast period.
The North America Pharmacogenomics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Pharmacogenomics Market report:
The North America Pharmacogenomics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Pharmacogenomics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Pharmacogenomics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Pharmacogenomics Market
